Stress Echo 2030: The Novel ABCDE-(FGLPR) Protocol to Define the Future of Imaging

Picano, E.; Ciampi, Q.; Cortigiani, L.; Arruda-Olson, A.M.; Borguezan-Daros, C.; de Castro e Silva Pretto, J.L.; Cocchia, R.; Bossone, E.; Merli, E.; Kane, G.C.; Varga, A.; Agoston, G.; Scali, M.C.; Morrone, D.; Simova, I.; Samardjieva, M.; Boshchenko, A.; Ryabova, T.; Vrublevsky, A.; Palinkas, A.; Palinkas, E.D.; Sepp, R.; Torres, M.A.R.; Villarraga, H.R.; Preradović, T.K.; Citro, R.; Amor, M.; Mosto, H.; Salamè, M.; Leeson, P.; Mangia, C.; Gaibazzi, N.; Tuttolomondo, D.; Prota, C.; Peteiro, J.; Van De Heyning, C.M.; D’Andrea, A.; Rigo, F.; Nikolic, A.; Ostojic, M.; Lowenstein, J.; Arbucci, R.; Haber, D.M.L.; Merlo, P.M.; Wierzbowska-Drabik, K.; Kasprzak, J.D.; Haberka, M.; Camarozano, A.C.; Ratanasit, N.; Mori, F.; D’Alfonso, M.G.; Tassetti, L.; Milazzo, A.; Olivotto, I.; Marchi, A.; Rodriguez-Zanella, H.; Zagatina, A.; Padang, R.; Dekleva, M.; Djordievic-Dikic, A.; Boskovic, N.; Tesic, M.; Giga, V.; Beleslin, B.; Di Salvo, G.; Lorenzoni, V.; Cameli, M.; Mandoli, G.E.; Bombardini, T.; Caso, P.; Celutkiene, J.; Barbieri, A.; Benfari, G.; Bartolacelli, Y.; Malagoli, A.; Bursi, F.; Mantovani, F.; Villari, B.; Russo, A.; De Nes, M.; Carpeggiani, C.; Monte, I.; Re, F.; Cotrim, C.; Bilardo, G.; Saad, A.K.; Karuzas, A.; Matuliauskas, D.; Colonna, P.; Antonini-Canterin, F.; Pepi, M.; Pellikka, P.A.; The Stress Echo 2030 Study Group of the Italian Society of Echocardiography and Cardiovascular Imaging. Stress Echo 2030: The Novel ABCDE-(FGLPR) Protocol to Define the Future of Imaging. J. Clin. Med. 2021, 10, 3641. https://doi.org/10.3390/jcm10163641

Abstract

[Abstract] With stress echo (SE) 2020 study, a new standard of practice in stress imaging was developed and disseminated: the ABCDE protocol for functional testing within and beyond CAD. ABCDE protocol was the fruit of SE 2020, and is the seed of SE 2030, which is articulated in 12 projects: 1-SE in coronary artery disease (SECAD); 2-SE in diastolic heart failure (SEDIA); 3-SE in hypertrophic cardiomyopathy (SEHCA); 4-SE post-chest radiotherapy and chemotherapy (SERA); 5-Artificial intelligence SE evaluation (AI-SEE); 6-Environmental stress echocardiography and air pollution (ESTER); 7-SE in repaired Tetralogy of Fallot (SETOF); 8-SE in post-COVID-19 (SECOV); 9: Recovery by stress echo of conventionally unfit donor good hearts (RESURGE); 10-SE for mitral ischemic regurgitation (SEMIR); 11-SE in valvular heart disease (SEVA); 12-SE for coronary vasospasm (SESPASM). The study aims to recruit in the next 5 years (2021-2025) ≥10,000 patients followed for ≥5 years (up to 2030) from ≥20 quality-controlled laboratories from ≥10 countries. In this COVID-19 era of sustainable health care delivery, SE2030 will provide the evidence to finally recommend SE as the optimal and versatile imaging modality for functional testing anywhere, any time, and in any patient.

Keywords

Effectiveness
Registry
Stress echocardiography
Sustainability

Editor version

https://doi.org/10.3390/jcm10163641

Rights

Atribución 4.0 Internacional

ISSN

2077-0383